Unforeseen In Animal Tests

News Headlines 16th Nov 2010 to 31st Dec 2010


 
“Pfizer Ordered to Pay $1.5 Million in Prempro Damages.”

Bloomberg. 31 December 2010.

“New Drug Approvals Fall in 2010 as Safety Concerns Slow U.S. FDA Decisions.”
Bloomberg. 30 December 2010

“FDA places experimental pain drugs on hold.”
Reuters. 28 December 2010.

“Regeneron pain drug put on clinical hold by FDA.”
Reuters. 27 December 2010 Reuters. 27 December 2010

“Obecure obesity drug fails trial. In contrast to a previous trial, Obecure's Histalean did not prevent weight gain by patients taking the antipsychotic drug Zyprexa.”
Globes. 24 December 2010

“Ahead of the Bell: Gilead drug failure no surprise. Analyst says late-stage clinical failure of Gilead's ambrisentan comes as no surprise”
Yahoo. 23 December 2010.
 
“Cumberland liver failure drug rejected.”

PM Live. 22 December 2010.

“Recombinant Human Growth Hormone (somatropin): Ongoing Safety Review - Possible Increased Risk of Death.”
FDA Medwatch. 22 December 2010

“Heartburn drugs linked to increased pneumonia risk.”
Reuters. 21 December 2010. 

“Astrazeneca Takes $445 Million Charge on Failure of MedImmune RSV Therapy.”
Bloomberg. 21 December 2010

“Anzemet (dolasetron mesylate): Drug Safety Communication - Reports of Abnormal Heart Rhythms.”
FDA Medwatch. 17 December 2010.
 
“Shares in UK pharmaceutical AstraZeneca drop 5% after US regulators further delay approval of its heart drug Brilinta.”

BBC website 17th Dec 2010

“Biogen reports four more Tysabri cases, one death.  79 confirmed PML cases as of Dec. 2, with 16 deaths”
Reuters. 16 December 2010.

“Some Medications Raise Risk of Auto Accidents.”
WSJ. 14 December 2010.

“Four Heart Treatments Questioned In Studies.”
WSJ. 14 December 2010.

“Lexicon's experimental arthritis drug disappoints.”
Reuters. 14 December 2010.

“Vioxx harmful even after patients stopped taking it.”
Reuters. 13 December 2010.

“Lilly Suspends Late-Stage Trial for Melanoma Drug in Which 12 People Died.”
Bloomberg. 13 December 2010
 
“Novartis pulls Zometa submission after breast cancer failure.”
InPharm. 13 December 2010.

“Major US breast cancer drug trial disappoints.”
The Independent. 11 December 2010.

“Pfizer pulls Thelin off market due to liver injury.”
Reuters. 10 December 2010
 
“US pharmaceutical company takes drug off market.”
Radio Australia News. 10 December 2010.

“Novartis's Failure With Zometa in Breast Cancer Stalls $1 Billion Booster.”
Bloomberg. 10 December 2010.

“J&J Loses First Trial on Warnings of Levaquin Risk.”
Bloomberg. 8 December 2010.
 
“J&J Loses Jury Trial on Warnings of Levaquin Risk.”
Bloomberg. 8 December 2010
 
“This posting includes 37 products with safety labeling changes to the following sections: BOXED WARNINGS, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS, PATIENT PACKAGE INSERT, and MEDICATION GUIDE.”
FDA Medwatch. 8 December 2010.
MedWatch November 2010 Safety Labeling Changes.
 
“French doctors demand to know why drug [benflourex] stayed on the market for so long.”
BMJ 2010; 341:c6882 doi: 10.1136/bmj.c6882. 3 December 2010
 
 
“Overall prevalence for a major congenital malformation after exposure to carbamazepine monotherapy in the first trimester.”
Intrauterine exposure to carbamazepine and specific congenital malformations: systematic review and case-control study

BMJ 2010; 341:c6581 doi: 10.1136/bmj.c6581 (Published 2 December 2010)

“Commonly used antidepressants may raise heart disease risk.”
Daily Telegraph. 1 December 2010.
 
 “Merck Stops Isentress Trial after Once a day Dosing Fails.”
E Max Health. 1 December 2010.

“Drug made me a sex-crazed transvestite.”
IOL. 30 November 2010.

“FDA staff note risks of AstraZeneca cancer drug.”
Reuters. 30 November 2010

“Glaxo’s Avodart Raises FDA Concern on Cancer Benefits.”
Bloomberg. 29 November 2010.

“FDA staff question Glaxo drug for prostate cancer.”
Reuters. 29 November 2010.
 
“The Nevada Supreme Court has upheld a $58 million judgment that was awarded to three Nevada women, who claimed they suffered breast cancer after taking the Prempro hormone replacement therapy made by Wyeth, which is now owned by Pfizer (PFE).”
‘Pfizer Loses in Court ... Again’  Seeking Alpha. 26 November 2010.

“Long-term statin treatment reduces the frequency of cardiovascular events, but safety and efficacy in patients with abnormal liver tests is unclear.”
‘Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis’
The Lancet, Early Online Publication, 24 November 2010 doi:10.1016/S0140-6736(10)61272-X Cite or Link Using DOI

“$12.6M awarded in drug case. Bone drug caused woman's jaw to disintegrate, jury says.”
Post and Courier. 23 November 2010.

“Canada announces news restrictions on diabetes drug”
Catholic.org. 22 November 2010.

“Darvon Pulled From Market by F.D.A.”
New York Times. 19 November 2010.

“Johnson & Johnson Hid Antibiotic’s Risk, Lawyer Says.”
Bloomberg. 16 November 2010

See the new VIN website: http://www.vivisectioninformation.com
Email VIN at vivisectionkills@hotmail.com

 

Related Articles:

From Dusk 'til Dawn
An Insider's View of the Growth of the Animal Liberation Movement

© Keith Mann
puppypincher@yahoo.co.uk